Abstract
ObjectiveStroma-rich tumours represent a poor prognostic subtype in stage II/III colon cancer (CC), with high relapse rates and limited response to standard adjuvant chemotherapy.DesignTo address the lack of efficacious therapeutic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have